Leung G K, Véniant M M, Kim S K, Zlot C H, Raabe M, Björkegren J, Neese R A, Hellerstein M K, Young S G
Gladstone Institute of Cardiovascular Disease, University of California, San Francisco, California 94141-9100, USA.
J Biol Chem. 2000 Mar 17;275(11):7515-20. doi: 10.1074/jbc.275.11.7515.
Microsomal triglyceride transfer protein (MTP) transfers lipids to apolipoprotein B (apoB) within the endoplasmic reticulum, a process that involves direct interactions between apoB and the large subunit of MTP. Recent studies with heterozygous MTP knockout mice have suggested that half-normal levels of MTP in the liver reduce apoB secretion. We hypothesized that reduced apoB secretion in the setting of half-normal MTP levels might be caused by a reduced MTP:apoB ratio in the endoplasmic reticulum, which would reduce the number of apoB-MTP interactions. If this hypothesis were true, half-normal levels of MTP might have little impact on lipoprotein secretion in the setting of half-normal levels of apoB synthesis (since the ratio of MTP to apoB would not be abnormally low) and might cause an exaggerated reduction in lipoprotein secretion in the setting of apoB overexpression (since the MTP:apoB ratio would be even lower). To test this hypothesis, we examined the effects of heterozygous MTP deficiency on apoB metabolism in the setting of normal levels of apoB synthesis, half-normal levels of apoB synthesis (heterozygous Apob deficiency), and increased levels of apoB synthesis (transgenic overexpression of human apoB). Contrary to our expectations, half-normal levels of MTP reduced the plasma apoB100 levels to the same extent ( approximately 25-35%) at each level of apoB synthesis. In addition, apoB secretion from primary hepatocytes was reduced to a comparable extent at each level of apoB synthesis. Thus, these results indicate that the concentration of MTP within the endoplasmic reticulum rather than the MTP:apoB ratio is the critical determinant of lipoprotein secretion. Finally, we found that heterozygosity for an apoB knockout mutation lowered plasma apoB100 levels more than heterozygosity for an MTP knockout allele. Consistent with that result, hepatic triglyceride accumulation was greater in heterozygous apoB knockout mice than in heterozygous MTP knockout mice.
微粒体甘油三酯转运蛋白(MTP)在内质网中将脂质转运至载脂蛋白B(apoB),这一过程涉及apoB与MTP大亚基之间的直接相互作用。最近对杂合子MTP基因敲除小鼠的研究表明,肝脏中MTP水平减半会降低apoB的分泌。我们推测,在MTP水平减半的情况下,apoB分泌减少可能是由于内质网中MTP:apoB比例降低,这会减少apoB-MTP相互作用的数量。如果这一假设成立,在apoB合成水平减半的情况下(因为MTP与apoB的比例不会异常低),MTP水平减半可能对脂蛋白分泌影响不大,而在apoB过表达的情况下(因为MTP:apoB比例会更低)可能会导致脂蛋白分泌过度减少。为了验证这一假设,我们研究了在apoB合成水平正常、apoB合成水平减半(杂合子Apob缺陷)以及apoB合成水平升高(人apoB转基因过表达)的情况下,杂合子MTP缺陷对apoB代谢的影响。与我们的预期相反,在每个apoB合成水平上,MTP水平减半均使血浆apoB100水平降低相同程度(约25 - 35%)。此外,在每个apoB合成水平上,原代肝细胞的apoB分泌减少程度相当。因此,这些结果表明,内质网中MTP的浓度而非MTP:apoB比例是脂蛋白分泌的关键决定因素。最后,我们发现apoB基因敲除突变的杂合子比MTP基因敲除等位基因的杂合子更能降低血浆apoB100水平。与该结果一致,杂合子apoB基因敲除小鼠的肝脏甘油三酯积累比杂合子MTP基因敲除小鼠更严重。